I honestly don't know how a partner for Lympro could be expected until the data on V2 is unveiled, or at least known behind the scenes. I do think that AMBS will partner on MANF by 2015. I do not think we will have to run phase 1/2 before that happens. I also think .15 is no where near where GC expects to be prior to an uplist.